A Study for a New Treatment of Non-Muscle Invasive Bladder Cancer

What we are studying

The purpose of this research study is look at the effects, good and bad, of an investigational drug to see if it has an effect on non-muscle invasive bladder cancer.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
  • Not Hispanic or Latino
  • Ages 18+

Eligibility Criteria

  • Patients can have either failed BCG induction therapy within a six-month period or have been successfully treated with BCG but subsequently found to have recurrence

What is involved

  • 15 clinic visits
  • Treatments with study medication weekly for 6 consecutive weeks-bladder catheterization
  • Biopsy



Contact Information

Study Coordinator
Nancy Lawlor
[email protected]

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.